In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Katy Wallace, principal consultant in the Life Sciences Practice at executive search firm, Berwick Partners, explains why the pharma industry needs diverse leadership in an Expert View piece. 10 December 2019
Pharmaceutical
US drugmaker Eli Lilly appears to have been so impressed with its newly-acquired subsidiary Loxo Oncology that it has asked it to take over the running of its oncology R&D. 5 December 2019
Pharmaceutical
A US Senate panel has all but confirmed that Stephen Hahn will be the next Commissioner of the Food and Drug Administration (FDA). 4 December 2019
Pharmaceutical
Germany-headquartered central nervous system (CNS) specialist Neuraxpharm Group today announced the expansion of its operations in Southern Europe with the launch of Neuraxpharm Portugal. 28 November 2019
Pharmaceutical
The Office of Women’s Health (OWH), part of the US Food and Drug has announced the selection of Kaveeta Vasisht as the Associate Commissioner for Women’s Health. 27 November 2019
Pharmaceutical
Vifor Pharma today announced the appointment of Lee Heeson as president international and a member of the executive committee as of February 1, 2020, with the news sending the Swiss drugmaker’s shares up 2.37% to 161.85 francs. 18 November 2019
Pharmaceutical
A little over five years ago, British drugmaker GlaxoSmithKline was riding high, following multiple years of strong sales and related year-on-year share price gains. 15 November 2019
Pharmaceutical
Swiss specialty drugmaker Santhera Pharmaceuticals this afternoon announced a strategic change to its management team with the appointment of Dario Eklund as chief executive effective December 1, 2019. 4 November 2019
Pharmaceutical
Shares of UK developer of inhaled therapeutics Vectura Group were up more than 1% at 84.07 pence, after it announced the appointment of Will Downie as chief executive and executive director of the company, effective November 7, 2019. 29 October 2019
Pharmaceutical
Enrique Conterno, senior vice president of Lilly and president of Lilly Diabetes and Lilly USA, will retire at the end of the year after 27 years of service with the company, US pharma major Eli Lilly announced today. 23 October 2019
Pharmaceutical
Mundipharma has named Matthew Homent its Ireland country manager, a position he has held on an interim basis since April of this year. 10 October 2019
Pharmaceutical
The Switzerland-based company will be led in its next phase of growth and innovation by an experienced management team and board, with proven track records in building sustainable high-growth businesses in pharmaceutical and consumer industries. 9 October 2019
Pharmaceutical
Louise Houson, who for three years has been the managing director (MD) for UK and Ireland at US pharma giant Merck & Co, has taken up a new USA-based role as global brand leader for HPV vaccines. 1 October 2019
Pharmaceutical
US pharma giant Pfizer’s executive chairman Ian Read has chosen to retire on December 31, 2019. 27 September 2019
Pharmaceutical
France-headquartered biopharma firm Genfit has announced an executive reshuffle appointing Dr Dean Hum as president of Genfit Corp and Dr Suneil Hosmane as head of Global Diagnostics. 27 September 2019
Pharmaceutical
Hisamitsu Pharmaceutical subsidiary Noven Pharmaceuticals has appointed Naruhito Higo as chief executive, replacing Jeff Mihm, who has resigned. 24 September 2019
Pharmaceutical
US biopharma company CASI Pharmaceuticals has announced the promotion of Larry Zhang to president. 19 September 2019
Pharmaceutical
Spanish dermatology specialist Almirall has announced that Mike McClellan will join the company as new chief financial officer (CFO) on November 11, 2019. 18 September 2019
Pharmaceutical
Danish allergy immunotherapy specialist ALK Abello today announced that Steen Riisgaard, ALK’s chairman, has informed the board of his intention to step down at the company's next Annual General Meeting (AGM), in March 2020. 13 September 2019
Pharmaceutical
Italian drugmaker Menarini has appointed Elcin Barker Ergun as chief executive. 12 September 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze